Is cardiovascular disease in women inevitable?: Preparing for menopause and beyond

Cardiology in Review

Volumn 19, Issue 2, 2011, Pages 76-80

  Johannes, Jimmy ^a   Bairey Merz, C Noel ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

cardiovascular disease; ischemic heart disease; menopause; prevention; women

Indexed keywords

AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; MORTALITY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; SECONDARY PREVENTION; SEX DIFFERENCE; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGING; CARDIOVASCULAR DISEASES; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS DISPARITIES; HORMONE REPLACEMENT THERAPY; HUMANS; LIFE STYLE; MALE; MENOPAUSE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; UNITED STATES; WOMEN'S HEALTH; YOUNG ADULT;

EID: 79951646717     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e318209a711     Document Type: Article

References (17)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics\2010 update: a report from the American Heart Association. Circulation. 2010;121:46-215.
2. Vaccarino V, Parsons L, Every NR, et al. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarc-tion 2 Participants. N Engl J Med. 1999;341:217-225. (Pubitemid 29334519)
3. Selby JV, Peng T, Karter AJ, et al. High rates ofco-occurrence ofhyperten-sion, elevated low-density lipoprotein cholesterol, and diabetes mellitus in a large managed care population. Am JManag Care. 2004;10:163-170. (Pubitemid 38332390)
4. Lewington S, Clarke R, Qizibash N, et al. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913. (Pubitemid 35472129)
5. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847. (Pubitemid 28213628)
6. Physical Activity Guidelines Advisory Committee. Physical activity guide-lines advisory committee report 2008. Washington, DC: U.S. Department of Health and Human Services; 2008.
7. Gierach GL, Johnson BD, Bairey Merz CN, et al. Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Eval-uation (WISE) Study. JAm Coll Cardiol. 2006;47(suppl 3):S50-S58.
8. Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or the menopausal transition. JAm Coll Cardiol. 2009;54:2366-2373.
9. Long T, Taubenheim A, Wayman J, et al. "The Heart Truth:" using the power of branding and social marketing to increase awareness of heart disease in women. Soc Mar Q. 2008;14:3-29.
10. Christian AH, Rosamond W, White AR. Nine-year trends and racial and ethnic disparities in women's awareness ofheart disease and stroke: an American Heart Association national study. J Womens Health. 2007;16: 68-81.
11. Mosca L, Linfante AH, Benjamin EJ, et al. National study of physician awareness and adherence to cardiovascular disesase prevention guidelines. Circulation. 2005;111:499-510. (Pubitemid 40204436)
12. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109:672-693. (Pubitemid 38198877)
13. Wessel TR, Arant CB, Olson MB, et al. Relationship ofphysical fitness vs. body mass index with coronary artery disease and cardiovascular events in women. JAMA. 2004;292:1179-1187. (Pubitemid 39167408)
14. Singh RB, Dubnov G, Niaz MA, et al. Effect of an Indo-Mediterranean diet on progression of coronary arter disease in high risk patients (Indo-Mediter-ranean Diet Heart Study): a randomized single-blind trial. Lancet. 2002;360: 1455-1461. (Pubitemid 35356323)
15. Knoops KT, de Groot LC, Kromhout D, et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European women and men. JAMA. 2004;292:1433-1439. (Pubitemid 39258335)
16. The ALLHAT Officers and Coordinators; ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibition or calcium channel blocker vs. diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002; 288: 2981-2997.
17. Walsh JM, Pignone M. Drug treatment of hyperlipidemia in women. JAMA. 2004;291:2243-2252. (Pubitemid 38608174)